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Abstract
Monepantel is a member of the recently identified class of anthelmintics known as the amino-acetonitrile derivatives
(AADs). Monepantel controls all major gastro-intestinal nematodes in sheep including those that are resistant to the classical
anthelmintics. Previous studies have shown that the Caenorhabditis elegans acr-23 and the Haemonchus contortus Hco-mptl-
1 genes may be prominent targets of monepantel. With this discovery it became possible to investigate the mode of action
of monepantel in nematodes at the molecular level. In the present study, we show that a C. elegans mutant acr-23 strain is
fully rescued by expressing the wild-type acr-23 gene. Moreover, we present a new mutant allele, and characterize acr-23
alleles genetically. We also show that acr-23 is expressed in body wall muscle cells, and provide therefore a possible
explanation for the paralysis caused by monepantel. Furthermore, genetic evidence suggests that the chaperone RIC-3 is
required for expression of full monepantel resistance. Finally, we present reconstitution of the C. elegans ACR-23 receptor in
Xenopus laevis oocytes and provide direct evidence of its modulation by monepantel. Conversely, co-injection of the
chaperone RIC-3 had no impact for channel reconstitution in X. laevis oocytes. These results reinforce the involvement of the
ACR-23 family in the mode of action of monepantel and advance our understanding of this new class of anthelmintics.
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Introduction
Parasitic infections by nematodes represent a serious threat to
the health of humans, companion animals and livestock. Three
classes of broad-spectrum anthelmintics have been available over
the past three to four decades to control these parasites.
Unfortunately some of these anthelmintics have, over time,
decreased in effectiveness with the appearance of resistant parasite
populations [1]. As a result, the development of compounds from
new drug classes that are able to control such resistant strains
became essential. The recently identified class of AAD anthel-
mintics offers an attractive solution, either used alone or
alternating with older anthelmintic classes. Importantly, the mode
of action of the AADs is different from that of other commercially
available anthelmintics [2,3,4].
To investigate the molecular mode of action of AAD
compounds, a genetic screen has been performed in the non-
parasitic nematode Caenorhabditis elegans, which is amenable to
genetic analyses [2]. This screen led to the identification of 44
mutant alleles. Among these, 27 alleles fell into a single class of
complementation and were found to disrupt the acr-23 gene. This
suggests that acr-23 represents a prominent target for AAD
molecules [2] including monepantel. Most mutant acr-23 strains
show complete resistance to monepantel when cultured under
standard conditions in the presence of micromolar doses of
monepantel. Furthermore, the search for parasitic nematodes
resistant to monepantel has led to the identification of Hco-mptl-1,
which is disrupted in monepantel-resistant strains of the parasitic
nematode Haemonchus contortus [2,4]. This screen was carried out in
natural hosts of this roundworm and confirms that a subunit from
the DEG-3 subfamily of receptors represents a major target for
monepantel [4]. With the discovery of acr-23, it was possible to
investigate the mode of action of AADs in nematodes. To date no
molecular analysis has been carried out. In particular, it is not
known if acr-23 is solely responsible for the resistance to the AADs
and how the ACR-23 protein responds to monepantel.
To answer these questions, we initiated the molecular charac-
terization of acr-23 in C. elegans. We have found that a mutant acr-
23 strain is fully rescued by expressing the wild-type acr-23 gene.
Moreover, the tissues that are targeted by monepantel have been
identified through the expression of a fusion protein between
ACR-23 and the green fluorescent protein (GFP). In addition, we
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have tested C. elegans mutants of several other subunits closely
related to acr-23 for their sensitivity to monepantel and their
genetic interaction with ric-3. We also checked for the potential of
the H. contortus Hco-mptl-1 gene to restore monepantel sensitivity in
C. elegans acr-23 mutants. Finally, we present functional expression
of the ACR-23 receptor in Xenopus oocytes and direct evidence of
its modulation by monepantel. Our work represents the first step
towards the molecular characterization of the acr-23 gene and its
involvement in the monepantel sensitivity phenotype. This work
enhances our understanding on how to control drug-resistant
nematodes and additionally supports the development of genetic
markers for the early detection of resistant genotypes in the field.
Materials and Methods
Strains, transgenics, and behavioural assay
C. elegans strains were grown at 20uC based on a previously
described general C. elegans procedure [5], except where specified.
Worms were fed with OP50 E. coli. N2 was used as a reference wild-
type C. elegans strain. Monepantel-resistant mutants were described
previously [2] except acr-23(tm2804)V and acr-23(cb110)V. Trans-
genic strains AP162 [acr-23(cb27)V; puIs4], AP176 [ric-3(md158)IV;
puIs3] and AP215 [acr-23(cb27)V; puIs4; puEx33] were generated by
microinjection. puIs3 and puIs4 are integrated arrays containing acr-
23(ORF)::gfp::unc-54 39UTR and pRF4. puEx33 is an extrachromo-
somal array containing Pmyo-3::mCherry::unc-54 39UTR. Other alleles
used in this study were acr-5(ok180)III, acr-23(ok2804)V, des-
2(u695)V, deg-3(u662)V, acr-18(ok1285)V and acr-23(cb92)V. Alleles
cb103 and cb98 have not been assigned to acr-23, since no mutations
were found in the acr-23 ORF [2]. ric-3(md158) is a 5-nucleotide
deletion that disrupts the reading frame at the beginning of the
second exon. It is very likely to correspond to a molecular null allele
[6]. nT1g is a semi-dominant marker for chromosomes IV and V. It
is lethal in the homozygous state and confers bright green
fluorescence in the pharynx of heterozygous animals. nT1g contains
a wild-type copy of acr-23. Deficiency eDf43 is a deletion between
positions211.81 and28.10 on chromosome V. eDf43 homozygotes
reach adulthood but are sterile and uncoordinated.
For the behavioral assay, worms that had been starved for 5 to
6 hours were transferred on fresh NGM-plates and left for 8 to
10 minutes prior to the locomotion measurement. Movies were
recorded with a 6406480 pixel USB camera (The imaging Source,
Germany) at 7.5 frames per second. Worms were illuminated
obliquely with red light-emitting diodes (LED) on a dark
background as previously reported [7]. Temperature was held
constant at 20uC with a thermoelectric Peltier system coupled to a
PID controller (Macshane Inc., Medina, OH). Temperature at the
top of the medium was measured with a thermistor probe and
fluctuated by less than 0.1uC during each movie. Movies were
analyzed with the Multi-Worm Tracker (MWT) software [8]. The
position of the center of mass of each object (worm) was smoothed
with a three-frame moving average. For each animal, instant speed
was calculated for each frame pair. Reversal and steering events
were flagged by comparing the angle made by three successive
positions of the object (angle range: 2180u to 180u). Angles with
absolute values over 150u were flagged as reversals. Angles
between 30u and 120u were flagged as steering events.
Growth kinetics was performed at 20uC by looking at germline
and vulval development, and by scoring the number of laid eggs
and hatched progeny. We scored the development of embryos that
were either transferred to, or laid directly on plates containing 0,
20 or 60 mM monepantel. To compare growth of ric-3; acr-23
mutants in the presence or absence of monepantel, we counted
progeny of four fertile young adult hermaphrodites after 3, 6 and 9
days at 20uC. In subsequent experiments the scoring was
simplified by assigning nine subjective growth levels that take into
account the volume of worms and the status of the bacterial lawn
after 9 days of culture: Level 1 corresponds to scarce coverage of
worms, with an even lawn of bacteria. At Level 2, there is a
moderate coverage of worms and patches of bacterial lawn while
at Level 3, plates are crowded with worms, and only spots of
bacteria are left. Level 4 corresponds to very crowded plates with
no remaining bacteria. Plates with starved worms that have dug
into the agar are assigned to Level 5. Intermediate levels (1.5, 2.5,
3.5 and 4.5) are also assigned for greater discrimination. Aging was
scored at 20uC on 80 wild-type or acr-23(cb27) fourth-stage (L4)
larvae. We scored body movement and analyzed the data using
the Log-rank test of OASIS [9]. Broods were analyzed by
transferring gravid hermaphrodites on fresh plates, until they
exhausted their sperm supply and laid oocytes instead of embryos.
DNA sequences
For acr-23(ok2804), the sequences flanking the 684 nt deletion
are: 59 taaattttacattttggaatgattcaata 39 and 59 ttaaaatctcaccttttgttc-
caagaac 39. Flanking sequences for acr-23(cb110) are 59 ggaaac-
taaccctatgttatactc 39 and 59 atctttgtaggtttgtagtttgtagttctt 39. acr-
23(cb103) is a G to A transition changing Alanine321 into
Threonine. Resequencing of alleles cb98 and cb78 did not reveal
mutations within the acr-23 ORF (sequencing covered all exons
and the ends of introns).
Constructions and complementation of mutants
The promoter and genomic coding sequence, including introns
from acr-23 (total of 12,581 bp) was amplified by Polymerase
Chain Reaction (PCR) using the Expand Long Template PCR
System (Roche) with the following primers: Ce-prom_A_frw1 (59
cattgcctggcaccagagataacaa 39) and Ce-acr23FL_rev1 (59 aagaaaat-
gattttccgtataccaaatatacc 39). The gfp coding sequence plus the unc-
54 39 untranslated region (UTR) was amplified by PCR from
vector pPD95.75 with the following primers: Cel-acr-23FL_gfp_frw1
(59 gaattaatttatatggctggtatatttggtatacggaaaatcattttcttagcttgcatgcctg-
caggtcgact 39) and unc-54 39UTR_r1 (59 aagggcccgtacggccgactag-
tagg 39). The Cel-acr-23FL_gfp_frw1 primer was designed to have a
50-nucleotide overhang to the Cel-acr-23 gene. Genomic DNA
fragments coding for acr-23 (10 ng/mL) and gfp (1.4 ng/mL) were co-
injected into adult germlines at equivalent molar ratios. Both
fragments recombined in vivo. pRF4 (a dominant allele of rol-6) was
used as an injection marker at 50 ng/mL [10]. Rescue was also
successful with an acr-23 genomic fragment alone (22 ng/mL). The
Author Summary
Worldwide, sheep and cattle farming are endangered by
anthelmintic-resistant gastro-intestinal nematodes. Mone-
pantel, a member of the recently identified class of
anthelmintics known as the amino-acetonitrile derivatives
(AADs) exhibits excellent efficacy against various species of
livestock-pathogenic nematodes and, more importantly,
overcomes existing resistances to the currently available
anthelmintics. Previous studies conducted with the non-
parasitic model nematode Caenorhabditis elegans have
found that acr-23 mutants are fully resistant to monepan-
tel. In this study, we confirm the role of acr-23 as a primary
target of monepantel by 1) restoring monepantel sensi-
tivity in the presence of extrachromosomal copies of wild-
type acr-23, 2) finding that ACR-23 is mainly expressed in
muscle cells, and 3) showing that acr-23 forms a
monepantel-sensitive channel in Xenopus oocytes.
ACR-23, a Monepantel Sensitive Channel
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presence of transgenes and the fusion of homologous products were
assessed by PCR. The mutations rescued were acr-23(cb27), acr-
23(cb103), acr-23(cb92), but also other alleles such as cb98 and cb78.
The promoter region, the signal peptide and the first four amino
acids from Cel-acr-23 (4841 bp) were amplified by PCR from
genomic DNA. The same procedure was used to amplify the Cel-
acr-23 39UTR (263 bp). The coding sequence of Hco-mptl-1
(1642 bp) was amplified by PCR from a cDNA plasmid clone
[4] using primers designed to have overlap with the acr-23 gene
including its promoter. All three PCR products were assembled
using a fusion-PCR approach. The final PCR fragment was gel
purified (NucleoSpin kit, Macherey Nagel) and cloned into a
pCRII-TOPO (Invitrogen). Plasmid DNA was purified using the
QIAprep Spin Miniprep kit (Qiagen) and sequenced using the
standard primers M13 forward and reverse as well as internal
primers.
Expression of acr-23::gfp was analyzed by epifluorescence and
confocal microscopy using several independent transgenic lines.
The pictures in the results section come from animals that have
integrated the transgene and co-express an extrachromosomal
array carrying the Pmyo-3::mCherry::unc-54 construct (pCFJ104
from addgene).
Cloning of acr-23 and ric-3 cDNA
RNA extraction, cDNA synthesis and PCR amplification were
performed as described [4]. In brief, total RNA was extracted from
a pool of approximately 50 nematodes, and 1 mg of total RNA
(DNase-treated) was reverse-transcribed to cDNA using a (dT)30
primer and SuperScript III Reverse Transcriptase (Invitrogen,
Carlsbad, CA). Primer sequences are available on request. Plasmid
DNA was purified and at least three clones of each construct were
sequenced and compared to the sequences published on
Wormbase (www.wormbase.org). The same procedure was used
to obtain the acr-23 sequences with an early (pAP326) or late
(pAP323) stop in frame (at position 326 and 1191, respectively)
and a D112N substitution (acr-23(cb101)) from C. elegans mutants.
The selected inserts were subcloned into a pT7-TS transcription
vector (that introduces X. laevis b-globin untranslated DNA to the
59 and 39 end of the gene) via the restriction sites inserted in the
primers. Plasmid DNA was purified with an EndoFree Plasmid
Purification kit (Qiagen).
Expression of ACR-23 proteins in Xenopus laevis oocytes
Capped cRNAs were synthesized (T7 mMessage mMachine kit,
Ambion, Austin, TX) from the linearized vectors containing the
different subunits. Isolation of oocytes, culturing of the oocytes,
and defolliculation was performed as described by Sigel [11,12].
Oocytes were micro-injected with 50 nl of cRNA solution (0.2 or
0.5 ng/nL) and then stored at 18uC in sterile filtered Barth’s
modified medium containing NaCl (88 mM), KCl (1 mM),
NaHCO3 (2.4 mM), HEPES (10 mM, pH 7.5), MgSO4
(0.82 mM), Ca(NO3)2 (0.34 mM), CaCl2 (0.41 mM), and penicil-
lin/streptomycin (100 U/mL). Recordings were routinely made
1–3 days post-cRNA injection.
Two-electrode voltage-clamp measurements
The measurements were performed at the Institute of Parasi-
tology, McGill University (Montre´al, Canada) and at the Institute
for Biochemistry and Molecular Medicine (IBMM, Bern, Swit-
zerland). Unless indicated otherwise, measurements were done in
ND96 medium containing 90 mM NaCl, 1 mM MgCl2, 1 mM
KCl, 1 mM CaCl2, and 5 mM HEPES, pH 7.4, at a holding
potential of 280 mV. Glass electrodes containing Ag|AgCl wire
were filled with 3 M KCl and had a resistance between 0.5 and
5 MV. Currents were measured using a GeneClamp 500B voltage
clamp (Axon Instrument) and with a custom-made two-electrode
voltage clamp amplifier in combination with an XY recorder (90%
response time, 0.1 s) or the current was digitized at 100 Hz using a
MacLab/200 (ADInstruments Ltd., Chalgrove, Oxfordshire, UK)
at McGill and IBMM, respectively. The amplifier was character-
ized by a linear response up to 20 mA. Ligands such as
acetylcholine, choline-chloride and nicotine (Sigma) were dissolved
in ND96 and applied in the absence or presence of modulatory
compounds for 20 s. The modulatory compounds were prepared
as a 10 mM stock solution in dimethyl sulfoxide (DMSO) and
were dissolved in external solution resulting in a maximal final
DMSO concentration of 0.1%. Agonists and modulatory com-
pounds were washed over the oocytes using a RC-3Z recording
chamber (Warner Instrument Inc.) at McGill. At IBMM, the
perfusion solution (6 ml/min) was applied through a glass capillary
with an inner diameter of 1.35 mm, the mouth of which was
placed approximately 0.4 mm from the surface of the oocyte,
enabling 70% solution change in 0.5 s [13]. To avoid contami-
nation, the perfusion system was cleaned between experiments by
washing with 100% DMSO after application of the AAD
derivatives. Data was obtained and analyzed using Clampex
software (Molecular Devices).
Results
acr-23 loss-of-function alleles confer resistance to
monepantel
In an attempt to further investigate the implication of the DEG-
3 subfamily proteins in their sensitivity to monepantel [2,4] we
characterized monepantel-resistant C. elegans isolates that were
identified through a large scale genetic screen [2]. Out of 44 alleles
recovered, 27 corresponded to mutations in the nicotinic
acetylcholine receptor (nAChR) gene acr-23 [2]. Among these,
acr-23(cb110) was described as a very strong allele although it was
merely a change from Alanine to Valine in the linker domain
between transmembrane domains 3 and 4 [2]. However, when we
resequenced this allele, we did not find the predicted mutation.
Instead, we found a 592-nucleotide deletion that disrupts the acr-
23 open reading frame, thus explaining the strong resistance of the
allele acr-23(cb110). Similarly, we found that allele acr-23(cb103),
which confers high resistance to monepantel corresponds to a
missense mutation in the linker domain of ACR-23. Finally, a new
allele of acr-23 was found by the C. elegans knockout consortium,
independently of resistance to monepantel. This allele, acr-
23(ok2804) carries a 684-nucleotide deletion that disrupts the
open reading frame before the first transmembrane domain and
confers strong resistance to monepantel. This finding represents an
additional and independent line of evidence that ACR-23 is a
target of monepantel. The sequences of the various alleles are
given in the methods section.
As already shown for the benzimidazoles and the gene ben-1
[14], one would predict that complementing mutant alleles with
wild-type copies of acr-23 would restore sensitivity to monepantel.
We therefore transformed monepantel-resistant acr-23 mutants
with wild-type copies of acr-23. Transgenic animals also expressed
the rol-6(su1006) marker DNA that causes a rolling phenotype.
Since the transgene was not integrated, we could compare
resistance to monepantel between rolling progeny and their non-
rolling siblings. The rescue was complete as transgenic adults
behaved like wild-type, in that they became paralyzed after 1–
2 hours upon exposure to the drug. When touched with a
platinum wire, paralyzed animals are stiff suggesting that the
paralysis caused by monepantel is spastic, rather than flaccid, as
ACR-23, a Monepantel Sensitive Channel
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observed for dead worms. Due to paralysis of the parent
hermaphrodite, embryos were not laid and the progeny hatched
inside the mother. Progeny bearing the wild-type acr-23 transgene
were paralyzed as well (Figure 1A). Such paralyzed animals
arrested development at larval stage 2 (L2), as judged by germline
development (Figure 1B). When put on normal growth medium,
transgenic strains produced 30–50% of rolling siblings, depending
on the line. The extrachromosomal array containing rol-6 and
wild-type acr-23 is therefore transmitted to 30–50% of the
progeny. In the presence of monepantel, only non-rolling animals
developed into fertile and mobile adults, while 100% of rolling
transgenic siblings were paralyzed and arrested their development
(Figure 1C,D).
In the parasite H. contortus, the gene with the highest similarity to
acr-23 is Hco-mptl-1. Several independent mutations were found in
the Hco-mptl-1 gene from H. contortus mutants with reduced
sensitivity for monepantel, implicating MPTL-1 as a likely target
for AAD action against H. contortus. [4]. We tried to complement
monepantel resistance of acr-23(cb27) mutants with a wild-type
Hco-mptl-1 cDNA driven by the C. elegans acr-23 promoter.
Although we obtained several stable transgenic lines, we never
observed complementation of acr-23 with H. contortus Hco-mptl-1
(data not shown). One possible explanation is the high degree of
divergence between MPTL-1 and ACR-23 amino acid sequences
(48.5% identity and 66.8% similarity; [4]). Another reason could
be the absence of introns in our transgene. There is evidence of
gene regulatory signals in introns and evidence that gene
expression and tissue specificity can be increased by including
introns [15,16]. We have used cDNA and not gDNA in our
transgene because the Hco-mptl-1 genomic sequence was too long
(.20 kbp) making its amplification difficult. However the impli-
cation of mptl-1 in rendering parasitic nematodes sensitive to
monepantel is valid because we have been able to reconstitute a
monepantel sensitive MPTL-1 channel in Xenopus oocytes (L.
Rufener, personal communication).
acr-23 alleles are haplo-insufficient
While acr-23(cb27) homozygotes are fully resistant to mone-
pantel [2], we found that acr-23(cb27)/nT1g or acr-23(ok2804)/
nT1g heterozygotes are partially affected by the drug. In the
Figure 1. Effects of monepantel on C. elegans and rescue of mutant acr-23. A) Adult N2 hermaphrodite with hatched embryos on 60 mM
monepantel. L1 and L2 larvae are paralyzed and coiled (carcass of mother is outlined). B) Higher resolution of an arrested L2 larva. The germline is
outlined. C) acr-23(cb27) animals carrying an extrachromosomal array containing wild-type acr-23 grown on standard NGM. Transgenic animals have a
rolling phenotype (red arrowhead; non transgenic worms are denoted by a black arrowhead in C and D). D) In presence of monepantel, only non-
rolling siblings are mobile and fertile. Transgenic animals are immobilized and dying or dead. Panels C) and D) show plates with the progeny of one
single rolling parent incubated for 6 days at 20uC. E) Phenotypes of homozygotic and heterozygotic acr-23(cb27). eDf43 is a deficiency that spans acr-
23 and neighboring genes. Depicted adult worms are one heterozygote, with dominant pharyngeal GFP expression (nT1g), and one non-glowing acr-
23(cb27) homozygote, both grown on 20 mM monepantel. White arrows indicate all embryos present in the uterus. Similar results were obtained with
acr-23(ok2804)/nT1g heterozygotes (not shown). Asterisks indicate the head. Bar, 50 mm. F) acr-23 mutants make fewer reversals. The rate of reversal
events, where worms shift from forward to backward locomotion or vice versa, was measured in starved worms crawling on food-free NGM plates at
20uC. n is the number of movies analyzed, each tracking 15 to 60 individuals over at least 1 minute. *, P-value = 6.4E-5 versus N2 by Student’s T-test
(two-tailed). Results are expressed as mean with s.e.m as error bars.
doi:10.1371/journal.ppat.1003524.g001
ACR-23, a Monepantel Sensitive Channel
PLOS Pathogens | www.plospathogens.org 4 August 2013 | Volume 9 | Issue 8 | e1003524
presence of 20 mM monepantel, heterozygotes are slightly
impaired in their movement while homozygotic mutants move
normally. In addition, in the presence of the drug, acr-23(cb27)/
nT1g heterozygotes produced significantly fewer embyros than
their homozygotic siblings: acr-23(cb27) homozygotes made
252623 embryos (n = 8 broods counted) and 237639 (n= 6) on
2 mM and 20 mM monepantel, respectively. Conversely, acr-
23(cb27)/nT1g heterozygotes laid only 161636 (n= 7) and
129625 (n= 8) eggs under the same conditions. When grown on
monepantel, acr-23(cb27)/nT1g or acr-23(ok2804)/nT1g heterozy-
gotes are also thinner and contain fewer embryos in utero than
homozygotes (Figure 1E). Such a semi-dominant effect could be
indicative for gain-of-function alleles. However, the molecular
lesions of most acr-23 alleles indicate that they are loss-of-function
mutations. We tested this hypothesis with the eDf43 deficiency,
which covers the acr-23 locus and several neighboring genes. We
found that eDf43+ heterozygotes are resistant to monepantel in
that no paralysis or L2 larval arrest were observed (Figure 1E). We
also tested eDf43 homozygotes. Such animals are viable, in spite of
the large deletion which causes uncoordinated movement and
sterility. In presence of monepantel, eDf43 homozygotes originat-
ing from a heterozygotic mother developed throughout adulthood
(Figure 1E). Therefore resistance to monepantel is likely to be
caused by loss of acr-23 activity. Taken together, our results
indicate that heterozygotic animals are resistant to monepantel
because acr-23 alleles are haplo-insufficient. In other words, full
sensitivity to monepantel requires 2 functional copies of acr-23.
acr-23 mutants move faster and reverse less frequently
Although acr-23 mutants are largely resistant to monepantel,
they have no obvious phenotype under standard culture conditions
[2]. In fact, we found similar growth rates of both wild-type and
acr-23(cb27) worms. Both took 70 hours to develop from the
deposited embyro to the fertile adult. In presence of 20 mM
monepantel, acr-23(cb27) grew at the same rate indicating that
micromolar concentrations of monepantel do not interfere with
the speed of embryonic and larval development. We also tested
longevity and did not notice differences between wild-type and acr-
23(cb27) animals: mean life spans were of 18.4260.37 days for
wild-type and 17.0460.56 days for acr-23(cb27) (P-value = 0.1901;
n = 80 worms per strain). We did not observe obvious morpho-
logical or locomotion defects in acr-23 mutants. We therefore
decided to explore the behavior in more detail. Using quantitative
analysis of locomotion, we found subtle alterations in the mutant.
When crawling on food-free medium, acr-23(cb27) animals had a
slightly increased average speed (0.103 body lengths/second
60.003 for acr-23(cb27) versus 0.08560.004 for N2; P-va-
lue = 1.1E-3 by Student’s t-test; n$24 experiments with at least
15 worms each) and more straight trajectories, concomitant with a
decreased steering rate (0.35 s2160.03 for mutant and 0.5460.04
for wild-type, P-value = 4.1E-7; n$24). We also observed a
decreased frequency of spontaneous reversals (Figure 1F).
ACR-23 is expressed in body wall muscles
In order to identify tissues that express ACR-23 and are
therefore targeted by monepantel, we generated transgenic C.
elegans that produce an ACR-23::GFP fusion protein driven by the
acr-23 promoter. The transgene was functional since it rescued
mutant acr-23 animals by restoring full sensitivity to monepantel.
By analyzing several independent lines, we found that an
integrated transgene expressed mainly in the body wall muscle
cells, as well as in a few unidentified head and tail neurons. The
fusion protein was visible from larval stage two, where it expressed
at low levels. Robust expression was observed from the third larval
stage on to adulthood (Figure 2A–D). Co-expression of myo-
3::mcherry was visible in the same cells, indicating that ACR-23 is
expressed in body-wall muscles [17,18]. No ACR-23::GFP
expression was found in embryos and first stage (L1) larvae.
Therefore, the onset of ACR-23 expression at larval stage 2
correlates with the observed L2 arrest in response to monepantel.
To test whether monepantel regulates ACR-23 expression, we
monitored ACR-23::GFP fusion protein levels in the absence and
presence of the compound. After 24 hours, worms were paralyzed
by the drug. We found that ACR-23::GFP levels were dramatically
low after exposure to monepantel (Figure 2E). However, this effect
was also observed with PI-kinase LET-512 [19], indicating that
monepantel may downregulate general protein synthesis which
could also simply be the consequences of dying worms rather than
the drug directly acting on gene expression level.
Functional characterization of the ACR-23 receptor
Functional expression in Xenopus laevis oocytes. 48 hours
after injection of acr-23 cRNAs into Xenopus oocytes, currents were
elicited by the addition of acetylcholine, choline or nicotine. 30 mM
choline elicited peak current amplitudes of 16856269 nA (n= 9).
Currents elicited by choline were characterized by a fast channel
opening followed by a slow desensitization. The oocytes rapidly
recovered to the baseline currents upon agonist removal. An
individual concentration-response curve with choline as the agonist
is shown in Figure 3A. No saturation was reached even at higher
choline concentrations (Figure 3A and B, filled circles). Injection of
mutant acr-23(cb101) cRNA produced only weak currents
(Figure 3B, filled squares), with peak current amplitudes of
756100 nA (n= 5) elicited by 64 mM choline. No detectable
current could be recorded in oocytes injected with nonsense-
mutated acr-23 cRNAs (pAP326 and pAP323), even at high
concentrations of choline (100 mM, data not shown).
Choline is the preferred agonist. Choline proved to be a
much more potent agonist of the ACR-23 channels than
acetylcholine. Acetylcholine (10 mM) elicited only 0.1660.04%
(n= 4) of the current amplitude obtained with 1 mM choline (data
not shown). Peak current amplitudes of 653644 nA (n= 7) were
recorded after exposure to 10 mM nicotine (data not shown),
which represent 40.4%62.2% of the currents elicited by 10 mM
choline in the same oocytes. Ivermectin was not able to agonize
the channel since no recordable current was recorded after the
application of the compound at 1 mM (data not shown).
Ion selectivity of ACR-23 channels. We previously found
that currents mediated by choline activated H. contortus DEG-3/
DES-2 channels permeated Ca2+ ions in addition to monovalent
cations [20]. This was detected indirectly by activation of a Ca2+-
activated chloride channel endogenous to the oocyte, resulting in a
shift of the reversal potential towards the chloride reversal
potential. It was interesting to see if ACR-23 channels were
permeable to Ca2+-ions. Instantaneous I–V curves were recorded
in standard medium (1 mM CaCl2), low calcium medium
(standard medium without CaCl2, plus 0.1 mM K-EGTA) and
high calcium medium (standard medium supplemented with
additional 9 mM CaCl2) in the presence or absence of 30 mM
choline. The reversal potential of the current elicited by choline
was 7.362.8 mV (n= 4) in standard medium, 7.363.1 mV (n= 4)
in low calcium medium and 5.062.2 mV (n= 4) in high calcium
medium. The reversal potential for chloride ions was determined
as 226.061.0 mV (n= 4), monitoring current through recombi-
nant a1b2c2 GABAA receptor channels. The fact that the reversal
potential does not significantly vary with the conditions indicates
that the channel is not permeable to Ca2+-ions. The reversal
potential in potassium medium, in which all Na+ was replaced by
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Figure 2. ACR-23 protein during C. elegans development. A) L2 larva expressing a acr-23::gfp transgene. Twisted morphology is caused by the
transformation marker rol-6(su1006). B) Same worm expressing myo-3::mCherry. C) and D) Expression in the adult. Bar, 50 mm. E) Analysis of ACR-
23::GFP expression in response to monepantel after 24 hours of exposure. Loading and general protein expression were tested with a-tubulin and
LET-512, respectively.
doi:10.1371/journal.ppat.1003524.g002
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K+, was measured at 8.362.9 mV (n= 4). Presumably, the
channel is permeable to both sodium and potassium ions.
Effects of monepantel on ACR-23 channels. To evaluate
the effect of monepantel on ACR-23 receptors, the drug was tested
as an agonist or as an allosteric modulator of choline. In the
absence of choline, monepantel showed a strong agonistic effect on
the channel at concentrations higher than 0.3 mM. Figure 4A
shows current traces of a concentration response curve of
monepantel. After exposure to the compound, the washing time
necessary to recover the initial membrane current was much
longer than with choline. As monepantel is a hydrophobic
compound, it may stick to the membrane of the oocytes making
wash-out slower. This, together with the fact that monepantel
opens the ACR-23 receptors more slowly than choline, created
this typical ‘‘V’’ shape current curves. At concentrations higher
than 3 mM, monepantel elicited currents that were too large to be
controlled with our amplifier. As no saturation could be reached, it
was not possible to measure an EC50 value. Nevertheless, when a
dose response curve was fitted to the data, the estimated Hill
coefficient of individual curves was higher than 2 indicating that
several molecules of monepantel must occupy the receptor to open
it. The fact that 3 mM monepantel elicited much larger currents
than 64 mM choline indicates that choline might be a partial
agonist of the channel. Non-injected oocytes failed to respond to
monepantel.
When monepantel was co-applied with 0.3 mM choline, the
measured currents were larger than with the drug alone and a
modulatory effect was evident at 0.1 mM monepantel (Figure 4B,
filled triangles and circles, respectively). The monepantel-mediated
potentiation of the current was measured at a concentration of
0.3 mM choline, which elicits only a small fraction of the maximal
current amplitude. It is interesting to note that the same AAD-
modulatory effect could be observed when monepantel was co-
applied with 1 mM acetylcholine or nicotine (data not shown). In
addition we have tested three different acr-23 constructions
harboring early (pAP326) or late (pAP323) stop codons, or a
D112N substitution in the extracellular loop, like in acr-23(cb101).
No detectable current could be recorded after injection of the
nonsense mutant acr-23 cRNAs, even when high doses of
monepantel (10 mM) were applied. The sensitivity to monepantel
of the ACR-23(cb101) channel was drastically reduced as 3 mM
monepantel generated only 10% of the current measured with the
Figure 3. Choline concentration dependence. A) Current traces
from a choline concentration response curve obtained from a Xenopus
oocyte expressing ACR-23 receptors. The bars indicate the time period
of choline perfusion. Choline concentrations are indicated above the
bars. B) Current amplitude measured in Xenopus oocytes expressing a
wild-type ACR-23 receptor (filled circles) or a mutant ACR-23 receptor
(filled squares) after choline perfusion. The mutant ACR-23 subunit
corresponding to allele acr-23(cb101) bears a D112N substitution in the
extracellular loop. Mean 6 SD of experiments carried out with 4–5
oocytes from two batches are shown.
doi:10.1371/journal.ppat.1003524.g003
Figure 4. Monepantel is a direct agonist of ACR-23 channel. A)
Current traces obtained from a Xenopus oocyte expressing ACR-23
upon perfusion with monepantel. The bars indicate the time period of
monepantel perfusion. Monepantel concentrations are indicated above
the bars. B) Averaged monepantel current amplitudes measured with
monepantel (filled circles), monepantel sulfone (open circles) and with
monepantel (filled triangles) and monepantel sulfone (open triangles)
supplemented with 0.3 mM choline. One point is in brackets as the
measured current reached the linear limit of the amplifier (20 mA),
preventing a precise measurement. The effect of monepantel on
mutant ACR-23(cb101) is shown by the filled squares. Mean 6 SEM of
experiments carried out with 3–6 oocytes from two batches are shown.
doi:10.1371/journal.ppat.1003524.g004
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wild-type ACR-23 receptor at the same drug concentration
(Figure 4B, filled squares). The Aspartic acid112 residue is located
in the A-loop of the extracellular domain of ACR-23 [2]. This and
several other loops in the extracellular domain of ACR-23 are
known to be important for binding agonists [21]. As expected, we
measured dramatically reduced currents with the mutant ACR-
23(cb101) receptor. Co-injection of wild-type acr-23 cRNA, with or
without ric-3 cRNA, did not significantly affect the modulation of
C. elegans ACR-23 channels by monepantel (data not shown, n = 3).
We tested the effects of monepantel sulfone on the ACR-23
receptor as this compound is the major metabolite of monepantel
in sheep [22]. It forms within hours of animal treatment, and has a
longer half-life than monepantel. The sulfone form of monepantel
was found to behave similarly to its parent compound, when used
alone or in combination with choline (Figure 4B, open circles and
triangles, respectively). The optical R-enantiomer of monepantel
(AAD-2224), which has no nematocidal effect, was inactive, and
failed to elicit current on its own or to potentiate choline responses
(data not shown, n= 3).
The chaperone RIC-3 is required for expression of full
monepantel resistance
The RIC-3 protein is required for the assembly and trafficking
of several nAChR channels and is therefore necessary for their
function in C. elegans [6]. Under standard conditions, homozygous
ric-3(md158) mutants grow slowly, are sub-fertile and slightly
impaired in their movement. We found that ric-3 mutants are
moderately resistant to monepantel. In fact, after four days of
growth in presence of 0.1 mM monepantel, 63% of ric-3(md158)
mutants developed into fertile adults, while 98% of N2 wild-type
worms arrested development as L2 larvae. However, when treated
with 10 mM monepantel, 100% of ric-3 animals arrested develop-
ment, while acr-23(cb27) or acr-23(ok2804) mutants were mostly
unaffected, since 90% reached adulthood (Figure 5A). Loss-of-
function mutations in additional nAChRs proteins such as ACR-
18, ACR-5, DES-2 and DEG-3 do not increase the resistance to
monepantel (Figure 5A). Similarly, the removal of ACR-5 did not
increase the slight resistance of ric-3(md158) mutants (data not
shown). When treated with low doses of monepantel, ric-3
mutants, albeit developing into fertile adults, are typically shorter
than untreated siblings (Figure 5B). We propose that the shorter
size is due to muscular contraction caused by the anthelmintic.
Our results suggest that ric-3 mutants are weakly resistant to
monepantel indicating that RIC-3 is required to cause maximal
drug effect. We hypothesized that RIC-3 could function in
promoting ACR-23 expression. If so, inactivation of ric-3 might
result in improper expression and activity of ACR-23 or, of other
proteins that regulate ACR-23 or respond to monepantel. To test
this hypothesis, we compared ACR-23::GFP expression in wild-
type and ric-3(md158) mutant animals, both in the presence and
absence of monepantel. Epifluorescence microscopy (data not
shown) and western blot analyses did not reveal significant
differences of ACR-23 expression (Figure 5C). These findings
suggest that RIC-3 does not regulate ACR-23 expression. We also
tested a possible synergy between RIC-3 and ACR-23 in the
response to monepantel. To do so, we constructed a ric-3; acr-23
double mutant. Similar to the single ric-3 mutant, the double
mutant grew very slowly, as it took 7 days at 20uC, for an embryo
to develop into a fertile adult. As a comparison, wild-type animals
take three days. Similarly, ric-3; acr-23 animals are slightly
impaired in their movement, grow slowly, and carry reduced
numbers of embryos, indicating that they are not totally healthy
[6]. We were however surprised to notice that in the presence of
20 mM monepantel, ric-3; acr-23 animals grew faster and healthier
than in its absence (Figure 5D). In fact, in the presence of the drug,
such double mutants had increased mobility and fertility. When
we compared the average morphology of treated and untreated ric-
3; acr-23 double mutants, we found that in the absence of
monepantel, among 20 randomly picked adults, 11 were clearly
sub-fertile, with a small gonad, few and small oocytes and reduced
numbers of embryos in the uterus (Figure 5F); eight had an
intermediate phenotype and one grew into a fertile adult with a
normally shaped germline (Figure 5G). When treated with 60 mM
monepantel, ric-3; acr-23 siblings developed as follows: one was
clearly sub-fertile, 13 were intermediate and nine had a normal
germline as shown in panel G. Thus monepantel partially rescues
the fertility defect caused by the ric-3 mutation in animals lacking
ACR-23. This observation indicates that proteins other than RIC-
3 and ACR-23 can mediate the biological effects of monepantel.
To explain increased fertility in the presence of monepantel, we
reasoned that if the compound hyper-activated ACR-23 (Figure 4),
it might also hyper-activate other nAChR proteins. We also
assumed that such nAChRs rely on RIC-3 for robust function [6].
Therefore hyper-activation by monepantel could compensate for
reduced nAChR function caused by the loss of RIC-3. As a
consequence monepantel would restore more efficient growth of
ric-3 mutants. To verify this and to identify putative secondary
targets of monepantel, we tested several homologs of ACR-23:
ACR-5, ACR-18 and the combined DES-2/DEG-3 proteins
[20,23]. We therefore compared the growth rate of the
corresponding mutants in the presence and absence of monepan-
tel. Loss-of-function mutations in either des-2 deg-3, or acr-18 did
not suppress the enhanced fertility on monepantel (Figure 5D).
However acr-5; ric-3; acr-23 triple mutants were less affected by
monepantel in that their growth was more robust either in the
absence or presence of monepantel (Figure 5D). As a comparison,
it should be noted that acr-23 single mutants grew much more
efficiently than any mutant combination containing ric-3(md158).
Our findings suggest that neither ACR-18 nor the DES-2 and
DEG-3 subunits act as secondary targets of monepantel. However,
an acr-5 mutation partially rescues the slow growth of ric-3
mutants, but independently of monepantel. The inactive enantio-
mer of monepantel did not lead to increased fertility of ric-3; acr-23
and ric-3; acr-23 des-2 deg-3 mutants indicating that the effect is
specific to the enantiomer, which has an anthelmintic activity
(Figure 5E).
Discussion
Wild-type ACR-23 is targeted by monepantel
The implication of DEG-3 subfamily channels in sensitivity to
monepantel is based on mutations found in nematodes that are
resistant to AADs [2,4,20]. Currently, 29 loss-of-function alleles
that confer resistance to monepantel map to the acr-23 locus.
Therefore, a better understanding of AAD action requires a more
profound investigation of acr-23 and the identification of other
putative targets of AADs in C. elegans and other species. In this
report, we provide three lines of evidence that ACR-23 is
responsible for the anthelmintic activity of monepantel in C.
elegans. First, wild-type acr-23 complements resistance to mon-
epantel. Second, ACR-23 is expressed in body wall muscles, which
are paralyzed upon treatment with monepantel. Third, mone-
pantel elicits a current from ACR-23 channels expressed in Xenopus
oocytes.
The simplest interpretation of the finding that sensitivity to
monepantel in acr-23 loss-of-function mutants can be restored by
adding wild-type copies of this gene, is that acr-23 is a main target
of monepantel. This point is strengthened by electrophysiological
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Figure 5. Effect of ric-3 on the response to monepantel. A) Dose response to monepantel. The average number of progeny reaching adulthood
after 3 days is plotted versus the concentration of monepantel. ric-3(md158) mutants are partially resistant to low doses of monepantel. B) ric-
3(md158) adult grown on 1 mM monepantel (bottom) compared to a sibling grown in absence of the drug (top). The reduced length is certainly
caused by muscle contraction due to monepantel. White arrows and arrowheads point at the heads and vulvae, respectively. C) ACR-23::GFP protein
levels in wild-type (lanes 1,2) and ric-3 (lanes 3,4) animals after 2 hours of exposure to 10 mM monepantel (lanes 2,4). a-Tubulin was used to verify
equal loading. D) Growth of wild-type and mutant strains on monepantel. Light gray (0 mM), dark gray (20 mM) and black (50 mM) bars represent the
growth rate after 9 days of culture. In the absence of monepantel, wild-type (N2) worms grow much faster than any of the mutants tested. Genotypes
are indicated. Values for growth rates are defined in the methods section (1, poor growth; 5, robust growth). acr-23 single mutants grew to level 5 in
less than 5 days, whereas ric-3; acr-23 double mutants reached level 2 in absence of monepantel, and level 4 in presence of the drug. E) Growth rates
after 9 days on the inactive R-enantiomer of monepantel. F) ric-3(md158); acr-23(cb27) adult grown in absence of monepantel. G) Adult ric-3(md158);
acr-23(cb27) sibling grown on 20 mM monepantel. In both panels (F and G), one germline arm is outlined. Arrowheads and arrows point at oocytes
and early embryos, respectively. The outlined germline arm shows robust production of gametes (panel G). Scale bar, 50 mm.
doi:10.1371/journal.ppat.1003524.g005
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experiments showing that ACR-23 expressed in Xenopus oocytes
reacts to monepantel. However, we also found that alleles (e.g.
cb98 and cb78) that do not correspond to coding sequence
alterations in the acr-23 ORF ([2] and this study), were rescued by
acr-23. We hypothesize that such alleles could affect either
promoter or other regulatory regions of acr-23. Alternatively,
these alleles could correspond to regulatory proteins that control
ACR-23 expression or function, and may therefore represent a
possible resistance site to monepantel action. Therefore the
cloning of the remaining monepantel-resistant alleles represents
an important step towards the understanding of the mode of action
of AAD anthelmintics.
Direct evidence for the interaction of AADs with a DEG-3
subfamily channel has been reported only once, where the H.
contortus DEG-3/DES-2 receptor was successfully expressed in
Xenopus oocytes [20]. It was shown that monepantel sulfone was
able to stimulate the choline-activated currents of H. contortus
DEG-3/DES-2 receptors in a concentration-dependent way,
acting as a type II positive allosteric modulator. However, three
observations argue against the fact that H. contortus DEG-3/DES-2
receptor could be identical to the primary target of the AADs.
First, almost all major mutations confering monepantel resistance
in C. elegans or H. contortus have been found in the ACR-23 or
MPTL-1 subunits respectively [2,4]. Second, of the different
AADs tested on this channel, only a half were able to stimulate the
channel when all of them had been shown to be active in vitro [20].
Third, species lacking an ACR-23/MPTL-1 homologue but
having a DEG-3/DES-2 channel (e.g. Pristionchus pacificus or
Strongyloides ratti) were shown to be resilient to monepantel
treatment [3]. We now show that the presence of wild-type
ACR-23 in C. elegans is necessary and possibly sufficient for the
response to monepantel.
ACR-23 functions as a monepantel-sensitive ion channel
in muscle cells
The effect of monepantel is visible at most developmental stages
and results in severe paralysis. When gravid adults were placed on
the drug, they became paralyzed as well as their progeny in utero.
These progeny arrested development at larval stage 2. We found
that an ACR-23::GFP fusion protein that rescues acr-23 mutants is
mainly expressed in body wall muscle cells. The expression was
visible from larval stage L2 to adulthood. The correlation between
ACR-23 expression starting at L2 and the developmental arrest at
the same stage corroborates the notion that ACR-23 is a primary
target of monepantel. However, we also found that L1 larvae that
hatched from eggs transferred on monepantel are severely
impaired in their movement, although they do not arrest
development and keep developing until L2. We postulate that
the sensitivity to monepantel at larval stage 1 might rely on
additional proteins that are sensitive to monepantel. As an
alternative, the amount of ACR-23 might be too low to be
detected early during development. ACR-23 was found in body
wall muscles that are arranged into four longitudinal bundles.
Body wall muscle cells have been stained with anti-MYO-3
antibodies [18]. acr-23::gfp and myo-3::mCherry transgenes expressed
in the same cells. Although nAChR proteins are expected to be
found at neuromuscular junctions, we did not see spots with higher
ACR-23 expression. Individual C. elegans body wall muscles have
both cholinergic and GABAergic inputs, which initiate contraction
and relaxation, respectively. A single gene (unc-49) encodes the
ionotropic GABA receptors present at the C. elegans neuromuscular
junction (NMJ) [24,25,26,27,28,29]. In contrast at least four
cholinergic receptors (unc-38, unc-29, unc-63 and acr-16) are found
at the NMJ of C. elegans [28,29,30]. Genetic ablation of those
cholinergic receptors has been shown to abolish all cholinergic
synaptic currents at the NMJ and severely impair C. elegans
locomotion [30]. Consequently, we propose that the diffuse
distribution of ACR-23 in muscle cells and its apparent absence
from the NMJ may correspond to a non-synaptic function of this
receptor in body wall muscles. In Ascaris suum muscle for instance,
Pennington and Martin concluded that extrasynaptic receptors of
this parasite contained two types of acetylcholine-activated ion
channels, which could serve as possible sites of action for
anthelmintic drugs [31]. Although we cannot fully exclude the
possibility that other subunits contribute to the native ACR-23-
containing receptor, and that the unidentified head and tail
neurons could account for the effect of monepantel, we suggest
that ACR-23 may function as an extrasynaptic homomeric
nicotinic receptor in the C. elegans body wall muscles.
Is choline the natural agonist of ACR-23 channels?
So far, four different receptors of the DEG-3 subfamilly of
receptors (DES-2/DEG-3 and ACR-23 from C. elegans, and DES-
2/DEG-3 and MPTL-1 from H. contortus) have been successfully
reconstituted in Xenopus oocytes ([20,23,32]; unpublished data).
For all of them, choline always proved to be a much more potent
agonist than acetylcholine. But in the case of the ACR-23
receptor, the fact that micromolar concentrations of monepantel
elicited much larger currents than millimolar concentrations of
choline, and that no current saturation could be obtained,
indicates that choline might only be a partial agonist of the
channel. To further improve our understanding of the ACR-23
channel properties, it may be of interest to screen a panel of
different choline analogues to search for a more potent agonist. As
mentioned above, data showing that ACR-23 subunits form a
homomeric receptor in vivo are still missing. Therefore, one could
argue that a missing subunit may explain the reduced sensitivity
towards acetylcholine when expressed in Xenopus oocytes. Inter-
estingly, it was shown that choline is interacting with the vertebrate
a7 receptors that are expressed in developing muscles prior to
synapse formation [33]. Due to this sensitivity to choline [34], the
a7 nAChR can be chemically excited, even after the natural
neurotransmitter (acetylcholine) has been enzymatically cleaved.
As a consequence, chemical neurotransmission involving the a7
nAChR is not limited to short distances as is the case for the other
nicotinic receptors. Fischer et al. showed that the a7 nAChR
subtype is playing an important role in the rat muscle development
for the endplate formation and/or stabilization [33]. It has been
reported that choline causes depolarization of muscle membranes
[35,36], and that the choline-evoked depolarization is enhanced
after the muscle denervation [33,37]. Choline also increases the
intracellular Ca2+ concentration at the muscle endplates [38].
While the in vivo function of the ACR-23 protein remains to be
elucidated we may speculate about it based on the present
findings. As ACR-23 has a preference for choline and is located
extrasynaptically on body wall muscle cells, a possible function
could be to increase muscle excitability by slightly depolarizing the
cells, thus making a contraction event more likely. By hyper-
activating this receptor, monepantel creates a general hyper-
contraction of the body wall muscles in nematodes, which are as a
consequence, completely paralyzed.
ACR-23 function in C. elegans
nAChRs are known to be necessary for mediating neuronal
stimulation and modulation [39]. In nematodes, they have been
implicated in various essential functions, like locomotion, egg
laying or pharyngeal pumping. ACR-23 belongs to the nematode
specific DEG-3 subfamilly of ionotropic nAChRs, which include
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eight members in C. elegans [3,40]. DEG-3, DES-2 and ACR-5
expression is restricted to neurons [40], while the expression of the
five other members has not been reported. Thus, to our
knowledge, ACR-23 is the first member of the DEG-3 subfamily
known to be expressed in muscles. The lack of an obvious mutant
phenotype in the absence of monepantel suggests that ACR-23 is
partially redundant with other nAChRs. However, using comput-
er-assisted locomotion analyses, we identified subtle alterations in
behavior, with decreased rates of spontaneous reversal and
steering, and slightly increased average speed. Since ACR-23 is
expressed both in body wall muscles and in yet unidentified
neurons, more work will be required to determine whether the
locomotion effects are due to an alteration in neuromuscular
transmission or in neuron to neuron transmission, or both.
ACR-23 function is modulated by RIC-3
The assembly of many nAChRs requires the assistance from
chaperones among which RIC-3 represents an example in C.
elegans [6]. We found that a ric-3 mutant is slightly resistant to
monepantel suggesting that the RIC-3 protein may be required for
the function of ACR-23. Unexpectedly, the growth of ric-3; acr-23
double mutants is more robust in the presence of monepantel than
in its absence. We propose that monepantel could activate other
nAChR channels that are poorly expressed or weakly functional in
a ric-3 mutant background. However, the nAChR proteins DES-2,
DEG-3, ACR-5 and ACR-18 appear not to be such candidates,
since their corresponding mutant alleles do not hinder the
increased growth rate on monepantel. Therefore, proteins
providing more efficient growth in the presence of the anthelmin-
tic remain to be discovered. Such proteins may represent
additional targets of monepantel. Interestingly, we have noticed
that in the absence of monepantel, acr-5; ric-3; acr-23 triple mutants
grow more efficiently than ric-3; acr-23 double mutants. Therefore
we hypothesize that ACR-5 might compete for a chaperone that is
distinct from RIC-3 and which is required for efficient growth.
We have shown that the levels of ACR-23 are not significantly
modulated by monepantel and by RIC-3. However, the weak
resistance of ric-3 mutants to monepantel indicates that RIC-3
functions as a minor player in the response to the anthelmintic.
Nevertheless, it remains possible, that RIC-3 regulates the
expression of ACR-23 but within a range that could not be
detected in our assay. Finally, we also consider the possibility that
proteins other than RIC-3 and ACR-23 could be required for the
response to monepantel. Such proteins could be encoded by
additional genes, which confer resistance to monepantel, but do
not correspond to the acr-23 open reading frame [2]. We predict
that the cloning of such genes will uncover new targets of
monepantel.
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